The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.

The FDA has announced new requirements for safety labeling on all opioid pain medications that place renewed emphasis on the risks associated with their long-term use. According to a July 31 news ...

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

Federal officials promised on Tuesday to crack down on a potent semisynthetic opioid found in gas store gummies, drinks and ...

The Food and Drug Administration announced on Thursday significant labeling changes that will affect all opioid pain ...

The City Council's Public Safety Committee heard about opioid trends and potential solutions to the drug crisis during a ...

A powerful new synthetic opioid, up to 1000 times stronger than morphine, has emerged in Adelaide’s street drug supply, and ...

A federal judge on July 28 ordered the opioid case against Publix closed due to both sides agreeing to a settlement.

Launched in July 2024, a north shore drug task force has seen a growing collaboration among law enforcement agencies and an uptick in murder charges for drug overdoses.

West Virginia will receive an estimated $980 million over the next 17 years from a global settlement of a class action ...

Members of the Oklahoma Opioid Abatement Board voted to approve grants for 15 public school districts on Thursday afternoon.